The Truth About Glucagon and Ketone Production

Glucagon is a peptide hormone made of 29 amino acids. It is produced and secreted by the alpha cells of the islets of Langerhans, a cluster of hormone producing cells inside the pancreas. It is synthesized from a larger precursor molecule called proglucagon, which is cut into different active fragments depending on the tissue. In the pancreas that fragment is glucagon. In the gut, the same precursor is processed into GLP-1 instead.

Glucagon was first isolated in the 1920s as a contaminant of early insulin preparations, and its role as insulin's metabolic opposite was established over the following decades.

The dominant trigger is a fall in blood glucose. Alpha cells sense low glucose directly and also respond to falling insulin, since insulin normally suppresses glucagon secretion from neighboring beta cells within the same islet.

• Low blood sugar: the primary and most direct signal.
• Amino acids: protein ingestion strongly stimulates glucagon, which helps the liver process incoming amino acids for gluconeogenesis and urea production.
• Sympathetic nervous system activity: exercise, stress and adrenaline all raise glucagon output.
• Reduced somatostatin and insulin signaling: both hormones normally restrain alpha cell output, so their withdrawal permits more glucagon release.

Glucagon binds to the glucagon receptor, a G protein coupled receptor found mainly on liver cells. This activates adenylate cyclase, which raises intracellular cyclic AMP (cAMP). Rising cAMP activates Protein Kinase A (PKA), which then phosphorylates a cascade of downstream enzymes.

That single phosphorylation cascade is responsible for essentially all of glucagon's effects: breaking down glycogen, building new glucose, and inhibiting the enzyme that produces malonyl-CoA, which is the step that opens the door to fat oxidation and ketogenesis described above.

Glucagon's textbook job is raising blood glucose, but its influence extends well past that. It regulates amino acid clearance and urea production in the liver, supports lipid mobilization from fat tissue, and current research also links it to appetite regulation, energy expenditure and liver fat content. This broader role is part of why some newer metabolic drugs are being designed to combine glucagon receptor activity with GLP-1 activity rather than avoid it.

Ketone bodies are small, water soluble molecules produced by the liver from fat when carbohydrate and insulin availability are low. They serve as an alternative fuel source that most tissues, including the brain, can burn when glucose is scarce. There are three ketone bodies produced in the human body.

• Acetoacetate (AcAc): the first ketone body formed, and the direct precursor to the other two.
• Beta hydroxybutyrate (BHB): made from acetoacetate, and the most abundant ketone body in the blood. This is the one measured by most home blood ketone meters.
• Acetone: a minor byproduct formed from acetoacetate breaking down spontaneously. It is not used as fuel and is largely exhaled through the lungs, producing the distinctive fruity breath odor associated with deep ketosis.

Ketogenesis takes place almost entirely inside liver mitochondria.

• Fatty acids released from fat tissue are transported into the liver and then into mitochondria via CPT-1.
• Beta oxidation breaks these fatty acids down into two carbon units of acetyl-CoA.
• When acetyl-CoA production outpaces what the citric acid cycle can absorb, the liver combines acetyl-CoA molecules into HMG-CoA using the enzyme HMG-CoA synthase.
• HMG-CoA is then cleaved into acetoacetate, which is either reduced into beta hydroxybutyrate or spontaneously broken down into acetone.
• The liver has no way to use ketones itself, so they are released into the bloodstream for other tissues to absorb.

Ketones exist to keep the brain and other high energy organs supplied with fuel when glucose is limited, without requiring the body to break down large amounts of muscle protein for gluconeogenesis. The brain cannot use fatty acids directly because they do not cross the blood brain barrier efficiently, but ketones can. In a prolonged fast, ketones can eventually supply a large share of the brain's energy needs, which spares glucose and protein for tissues that still require it.

This is the single most important distinction on this entire page.

Nutritional ketosisA controlled, self limiting state where blood ketones typically sit somewhere in a modest range. Insulin is present at low but functional levels, which caps how high ketone production can climb and keeps blood pH normal.

Diabetic ketoacidosisA dangerous, unregulated state that occurs almost exclusively with a near total absence of insulin, most commonly in type 1 diabetes. Without insulin to restrain lipolysis, fatty acid delivery to the liver becomes essentially unlimited, ketone levels climb far higher than in nutritional ketosis, and blood becomes acidic. This is a medical emergency, not an extension of dietary ketosis.

The presence of even a small amount of functioning insulin is what separates a normal metabolic state from a medical crisis, which is the entire thread running through this article.